Development of ulcerative colitis and its associated colorectal neoplasia as a model of the organ-specific chronic inflammation-carcinoma sequence

Pathology International

Volumn 62, Issue 6, 2012, Pages 368-380

  Okayasu, Isao ^a,b  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

Intestinal commensal bacteria; Organ specific chronic inflammation; p53 mutation; Tissue remodeling; Tumorigenesis; Ulcerative colitis

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 23; PROTEIN P53;

BACTEROIDES VULGATUS; CANCER PROGNOSIS; CARCINOGENESIS; CHRONIC CHOLECYSTITIS; CHRONIC HEPATITIS; CHRONIC INFLAMMATION; CLOSTRIDIUM; COLORECTAL CARCINOMA; COLORECTAL TUMOR; COMMENSAL; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE COURSE; DNA DAMAGE; EPSTEIN BARR VIRUS INFECTION; ESCHERICHIA COLI; ESOPHAGEAL ADENOCARCINOMA; FUSOBACTERIUM VARIUM; G1 PHASE CELL CYCLE CHECKPOINT; GASTRITIS; GASTROESOPHAGEAL REFLUX; GENE MUTATION; GENOMIC INSTABILITY; HELICOBACTER INFECTION; HUMAN; INNATE IMMUNITY; INTERSTITIAL PNEUMONIA; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; LEYDIG CELL; LYMPHOCYTIC THYROIDITIS; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; MUCOSAL IMMUNITY; MYOFIBROBLAST; OXIDATIVE STRESS; PAPILLOMA VIRUS; PRIORITY JOURNAL; REVIEW; STEM CELL; STOMACH ADENOCARCINOMA; STROMA CELL; TELOMERE SHORTENING; TH17 CELL; TISSUE REGENERATION; ULCERATIVE COLITIS; UTERINE CERVICITIS;

ADENOCARCINOMA; BACTERIAL INFECTIONS; BACTERIAL TRANSLOCATION; COLITIS, ULCERATIVE; COLON; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMATION; INTESTINAL MUCOSA; MACROPHAGE ACTIVATION; MALE; ORGAN SPECIFICITY; RECTUM;

EID: 84861338028     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2012.02807.x     Document Type: Review

References (81)

1. Koshida Y, Koizumi W, Sasabe M, Kato Y, Okayasu I. Association of Helicobacter pylori-dependent gastritis with gastric carcinomas in young Japanese patients: Histopathological comparison of diffuse and intestinal type cancer cases. Histopathology 2000; 37: 124-30.
2. 1WAF1/CIP1 and cyclin D1 are associated with malignant transformation in gastric hyperplastic polyps. Am J Clin Pathol 2001; 115: 224-34.
3. Bayerdörffer E, Neubauer A, Rudolph B etal. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet 1995; 345: 1591-4.
4. Tanigawa H, Uesugi H, Mitomi H, Saigenji K, Okayasu I. Possible association of active gastritis, featuring accelerated cell turnover and p53 overexpression, with cancer development at anastomoses after gastrojejunostomy. Comparison with gastroduodenostomy. Am J Clin Pathol 2000; 114: 354-63.
5. Fukayama M. Epstein-Barr virus and gastric carcinoma. Pathol Int 2010; 60: 337-50.
6. Devroede GJ, Taylor WF, Sauer WG. Cancer risk and life expectancy of children with ulcerative colitis. N Engl J Med 1971; 285: 17-21.
7. Okayasu I, Fujiwara M, Takemura T, Toyoshima H, Takano T, Nakamura K. Development of colorectal cancer in ulcerative colitis: Clinicopathological study of 347 patients and new concepts of cancer development from analysis of mucosal cell proliferation activity. Stomach and Intestine (Tokyo) 1993; 28: 171-9.
8. Sada M, Igarashi M, Yoshizawa S etal. Dye spraying and magnifying endoscopy for dysplasia and cancer surveillance in ulcerative colitis. Dis Colon Rectum 2004; 47: 1816-23.
9. WAF1 expression in chronic cholecystitis: Comparison with background mucosa of gallbladder carcinomas. Histopathology 2000; 36: 54-61.
10. Yanagisawa N, Mikami T, Saegusa M, Okayasu I. More frequent beta-catenin exon 3 mutations in gallbladder adenomas than in carcinomas indicate different lineages. Cancer Res 2001; 61: 19-22.
11. Yanagisawa N, Mikami T, Yamashita K, Okayasu I. Microsatellite instability in chronic cholecystitis is indicative of an early stage in gallbladder carcinogenesis. Am J Clin Pathol 2003; 120: 413-7.
12. Yanagisawa N, Yamashita K, Kuba T, Okayasu I. Sporadic TP53 transition mutations in chronic cholecystitis are possibly linked to gallbladder carcinogenesis. Anticancer Res 2010; 30: 4443-50.
13. Okayasu I, Fujiwara M, Hara Y, Tanaka Y, Rose NR. Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma. A study of surgical cases among Japanese, and white and African Americans. Cancer 1995; 76: 2312-8.
14. Okayasu I. The Relationship of Lymphocytic Thyroiditis to the development of thyroid carcinoma. Endocr Pathol 1997; 8: 225-30.
15. WAF1 expression in lymphocytic thyroiditis and thyroid tumors. Clin Immunol Immunopathol 1998; 88: 183-91.
16. Nose F, Ichikawa T, Fujiwara M, Okayasu I. Up-regulation of cyclooxygenase-2 expression in lymphocytic thyroiditis and thyroid tumors: Significant correlation with inducible nitric oxide synthase. Am J Clin Pathol 2002; 117: 546-51.
17. McGovern D, Powrie F. The IL23 axis plays a key role in the pathogenesis of IBD. Gut 2007; 56: 1333-6.
18. Sarra M, Pallone F, MacDonald TT, Monteleone G. IL-23/IL-17 axis in IBD. Inflamm Bowel Dis 2010; 16: 1808-13.
19. Annuziato F, Cosmi L, Santarlasci V etal. Phenotypic and functional features of human Th17 cells. J Exp Med 2007; 204: 1849-61.
20. Kobayashi T, Okamoto S, Hisamatsu T etal. IL23 differentially regulates the TH1/Th17 balance in ulcerative colitis and Crohn's disease. Gut 2008; 57: 1682-9.
21. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993; 75: 253-61.
22. Kühn R, Löhler J, Rennick D etal. Interleukin-10 deficient mice develop chronic enterocolitis. Cell 1993; 75: 263-74.
23. Sellon RK, Tonkonogy S, Schultz M etal. Resident enteric flora are necessary for development of spontaneous colitis and immune system activation in IL-10-deficient mice. Infect Immun 1998; 66: 5224-31.
24. Ohkusa T, Okayasu I, Tokoi S, Ozaki Y. Bacterial invasion into the colonic mucosa in ulcerative colitis. J Gastroenterol Hepatol 1993; 8: 116-8.
25. Ohkusa T, Okayasu I, Ogihara T, Morita K, Ogawa M, Sato N. Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis. Gut 2003; 52: 79-83.
26. Ohkusa T, Sato N, Ogihara T, Morita K, Ogawa M, Okayasu I. Fusobacterium varium localized in the colonic mucosa of patients with ulcerative colitis stimulates species-specific antibody. J Gastroenterol Hepatol 2002; 17: 849-53.
27. Yamashita K, Yasuda S, Kuba T, Otani Y, Fujiwara M, Okayasu I. Unique characteristics of rectal carcinoma cell lines derived from invasive carcinomas in ulcerative colitis patients. Cancer Sci 2004; 95: 211-7.
28. Yoshida T, Sekine T, Aisaki K, Mikami T, Kanno J, Okayasu I. CITED2 is activated in ulcerative colitis and induces p53-dependent apoptosis in response to butyric acid. J Gastroenterol 2011; 46: 339-49.
29. Ohkusa T, Yoshida T, Sato N, Watanabe S, Tajiri H, Okayasu I. Commensal bacteria can enter colonic epithelial cells and induce proinflammatory cytokine secretion: A possible pathogenic mechanism of ulcerative colitis. J Med Microbiol 2009; 58: 535-45.
30. Nomura T, Ohkusa T, Okayasu I etal. Mucosa-associated bacteria in ulcerative colitis before and after antibiotic combination therapy. Aliment Pharmacol Ther 2005; 21: 1017-27.
31. Ohkusa T, Nomura T, Terai T etal. Effectiveness of antibiotic combination therapy in patients with active ulcerative colitis: A randomized, controlled pilot trial with long-term follow-up. Scand J Gastroenterol 2005; 40: 1334-42.
32. Ohkusa T, Kato K, Terao S etal. Newly developed antibiotic combination therapy for ulcerative colitis: A double-blind placebo-controlled multicenter trial. Am J Gastroenterol 2010; 105: 1820-29.
33. WAF1/CIP1 expression in ulcerative colitis. Mod Pathol 1999; 12: 604-11.
34. Hibi K, Mitomi H, Koizumi W, Tanabe S, Saigenji K, Okayasu I. Enhanced cellular proliferation and p53 accumulation in gastric mucosa chronically infected with Helicobacter pylori. Am J Clin Pathol 1997; 108: 26-34.
35. Yoshida T, Haga S, Numata Y etal. Disruption of the p53-p53R2 DNA repair system in ulcerative colitis contributes to colon tumorigenesis. Int J Cancer 2006; 118: 1395-403.
36. Yoshida T, Mikami T, Mitomi H, Okayasu I. Diverse p53 alterations in ulcerative colitis-associated low-grade dysplasia: Full-length gene sequencing in microdissected single crypts. J Pathol 2003; 199: 166-75.
37. Fujii S, Fujimori T, Kawamata H etal. Development of colonic neoplasia in p53 deficient mice with experimental colitis induced by dextran sulphate sodium. Gut 2004; 53: 710-16.
38. Okayasu I, Hana K, Yoshida T, Mikami T, Kanno J, Fujiwara M. Significant increase of colonic mutated crypts in ulcerative colitis correlatively with duration of illness. Cancer Res 2002; 62: 2236-8.
39. Okayasu I, Hana K, Tsuruta T etal. Significant increase of colonic mutated crypts correlates with age in sporadic cancer and diverticulosis cases, with higher frequency in the left- than right-side colorectum. Cancer Sci 2006; 97: 362-7.
40. Risques RA, Lai LA, Brentnall TA etal. Ulcerative colitis is a disease of accelerated colon aging: Evidence from telomere attrition and DNA damage. Gastroenterolgy 2008; 135: 410-18.
41. Risques RA, Lai LA, Himmetoglu C etal. Ulcerative colitis-associated colorectal cancer arises in a field of short telomeres, senescence, and inflammation. Cancer Res 2011; 71: 1669-79.
42. Matsumoto N, Yoshida T, Okayasu I. High epithelial and stromal genetic instability of chromosome 17 in ulcerative colitis-associated carcinogenesis. Cancer Res 2003; 63: 6153-61.
43. Matsumoto N, Yoshida T, Yamashita K, Numata Y, Okayasu I. Possible alternative carcinogenesis pathway featuring microsatellite instability in colorectal cancer stroma. Br J Cancer 2003; 89: 707-12.
44. Yagishita H, Yoshida T, Ishiguro K, Numata Y, Okayasu I. Epithelial and stromal genetic instability linked to tumor suppressor genes in ulcerative colitis-associated tumorigenesis. Scand J Gastroenterol 2008; 43: 559-66.
45. Shiraishi H, Mikami T, Aida J etal. Telomere shortening in Barrett's mucosa and esophageal adenocarcinoma and its association with loss of heterozygosity. Scand J Gastroenterol 2009; 44: 538-44.
46. Ishiguro K, Yoshida T, Yagishita H, Numata Y, Okayasu I. Epithelial and stromal genetic instability contributes to genesis of colorectal adenomas. Gut 2006; 55: 695-702.
47. Ogawa T, Yoshida T, Tsuruta T, Saigenji K, Okayasu I. Genetic instability on chromosome 17 in epithelium of nonpolypoid colorectal carcinomas, as compared to polypoid lesions. Cancer Sci 2006; 97: 1335-42.
48. Umeto H, Yoshida T, Araki K, Yagishita H, Mikami T, Okayasu I. Appearance of epithelial and stromal genomic instability in background colorectal mucosa of sporadic colorectal cancer patients: Relation to age and gender. J Gastroenterol 2009; 44: 1036-45.
49. Riddell RH, Goldman H, Ransohoff DF etal. Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applications. Hum Pathol 1983; 14: 931-68.
50. INK4A and Bax in p53 wild/p53-overexpressing crypts in ulcerative colitis-associated tumours. Br J Cancer 2004; 91: 1081-8.
51. Goh AM, Coffill CR, Lane DP. The role of mutant p53 in human cancer. J Pathol 2011; 223: 116-26.
52. 6-methylguanine DNA methyltransferase (MGMT) and hMLH1 in ulcerative colitis-associated tumors: Comparison with sporadic colonic tumors. Am J Clin Pathol 2007; 127: 366-73.
53. Connel WR, Talbot IC, Harpaz N etal. Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis. Gut 1994; 35: 1419-23.
54. Hinton JM. Risk of malignant change in ulcerative colitis. Gut 1966; 7: 427-32.
55. Mikami T, Mitomi H, Hara A etal. Decreased expression of CD44, alpha-catenin, and deleted colon carcinoma and altered expression of beta-catenin in ulcerative colitis-associated dysplasia and carcinoma, as compared with sporadic colon neoplasms. Cancer 2000; 89: 733-40.
56. Mikami T, Yoshida T, Numata Y etal. Invasive behavior of ulcerative colitis-associated carcinoma is related to reduced expression of CD44 extracellular domain: Comparison with sporadic colon carcinomas. Diagn Pathol 2011; 6: 30.
57. Floren CH, Benoni C, Willen R. Histologic and colonoscopic assessment of disease extension in ulcerative colitis. Scand J Gastroenterol 1987; 22: 459-62.
58. th edn. Massachusetts: Blackwell Science Ltd, 2003; 485-505.
59. Mitsuhashi J, Mikami T, Saigenji K, Okayasu I. Significant correlation of morphological remodeling in ulcerative colitis with disease duration and between elevated p53 and p21 expression in rectal mucosa and neoplastic development. Pathol Int 2005; 55: 113-21.
60. Okayasu I, Yoshida T, Mikami T etal. Mucosal remodeling and alteration of stromal microenvironment in ulcerative colitis as related to colorectal tumorigenesis. In: O'Connor MB, ed. Ulcerative Colitis/Book 1. Rijeka: InTech Open Access Publisher, 2011; 241-56.
61. Okayasu I, Yoshida T, Mikami T etal. Mucosal remodeling in long-standing ulcerative colitis with colorectal neoplasia: Significant alterations of NCAM+ or SMA+ subepithelial myofibroblasts and interstitial cells. Pathol Int 2009; 59: 701-11.
62. Araki K, Mikami T, Yoshida T etal. High expression of HSP47 in ulcerative colitis-associated carcinomas: Proteomic approach. Br J Cancer 2009; 101: 492-7.
63. Okayasu I, Mikami T, Yoshida T etal. Cytoglobin expression of rectal subepithelial myofibroblasts: Significant alterations of cytoglobin+ stromal cells in long-standing ulcerative colitis. Histol Histopathol 2011; 26: 679-88.
64. Kang SS, Bloom SM, Norian LA etal. An antibiotic-responsive mouse model of fulminant ulcerative colitis. PLoS Med 2008; 5: e41.
65. Garrett WS, Lord GM, Punit S etal. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 2007; 131: 33-45.
66. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990; 98: 694-702.
67. Okayasu I, Yamada M, Mikami T, Yoshida T, Kanno J, Ohkusa T. Dysplasia and carcinoma development in a repeated dextran sulfate sodium-induced colitis model. J Gastroenterol Hepatol 2002; 17: 1078-83.
68. Okayasu I, Ohkusa T, Kajiura K, Kanno J, Sakamoto S. Promotion of colorectal neoplasia in experimental murine ulcerative colitis. Gut 1996; 39: 87-92.
69. Fujiwara M, Kaneko T, Iwana H etal. Inhibitory effects of Bifidobacterium longum on experimental ulcerative colitis induced by synthetic dextran sulfate sodium. Digestion 2003; 67: 90-95.
70. Ohkusa T, Okayasu I, Tokoi S, Araki A, Ozaki Y. Changes in bacterial phagocytosis of macrophages in experimental ulcerative colitis. Digestion 1995; 56: 159-64.
71. Tokoi S, Ohkusa T, Okayasu I, Nakamura K. Population changes in immunoglobulin-containing mononuclear cells in dextran sulfate sodium-induced colitis. J Gastroenterol 1996; 31: 182-8.
72. Arai Y, Takanashi H, Kitagawa H, Okayasu I. Involvement of interleukin-1 in the development of ulcerative colitis induced by dextran sulfate sodium in mice. Cytokine 1998; 10: 890-96.
73. Arai Y, Takanashi H, Kitagawa H, Wirth KJ, Okayasu I. Effect of icatibant, a bradykinin B2 receptor antagonist, on the development of experimental ulcerative colitis in mice. Dig Dis Sci 1999; 44: 845-51.
74. Tomita Y, Jyoyama H, Kobayashi M etal. Role of group IIA phospholipase A2 in rat colitis induced by dextran sulfate sodium. Eur J Pharmacol 2003; 472: 147-58.
75. Kajiura K, Ohkusa T, Okayasu I. Relationship between fecal bile acids and the occurrence of colorectal neoplasia in experimental murine ulcerative colitis. Digestion 1998; 59: 69-72.
76. Mitamura T, Sakamoto S, Sassa S, Suzuki S, Kudo H, Okayasu I. The more an ulcerative colitis is repeated, the more the risk of colorectal carcinogenesis is increased in mice. Anticancer Res 2002; 22: 3955-61.
77. Uchima H, Eishi Y, Takemura T, Hirokawa K. Immunohistochemical studies of ulcerative colitis, with special reference to localization of immunoglobins, secretory component, and lysozyme in view of suffering periods. Acta Pathol Jpn 1983; 33: 1183-96.
78. Kobayashi Y, Inoue T. Principles of data mining in toxicogenomics. In: Sahu S, ed. Toxicogenomics: A Powerful Tool for Toxicity Assessment. Chichester, West Sussex: John Wiley & Sons, 2008; 57-84.
79. Osada T, Ohkusa T, Okayasu I etal. Correlations among total colonoscopic findings, clinical symptoms, and laboratory markers in ulcerative colitis. J Gastroenterol Hepatol 2008; 23 (Suppl. 2): S262-7.
80. Fujiwara M, Okayasu I, Oritsu M etal. Significant increase in prostaglandin E-main urinary metabolite by laxative administration: Comparison with ulcerative colitis. Digestion 2000; 61: 201-6.
81. Tarao K, Rino Y, Ohkawa S etal. Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis. Cancer 1999; 86: 589-95.